These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33687876)

  • 1. Water Mapping and Scoring Approaches to Predict the Role of Hydration Sites in the Binding Affinity of PAK1 Inhibitors.
    Biswal J; Jayaprakash P; Rayala SK; Venkatraman G; Rangasamy R; Poopandi S; Jeyakanthan J
    Comb Chem High Throughput Screen; 2022; 25(4):660-676. PubMed ID: 33687876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Pak1 inhibitors using water thermodynamic analysis.
    Biswal J; Jayaprakash P; Suresh Kumar R; Venkatraman G; Poopandi S; Rangasamy R; Jeyaraman J
    J Biomol Struct Dyn; 2020 Jan; 38(1):13-31. PubMed ID: 30661460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach.
    Agarwal S; Kashaw SK
    J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WaterMap and Molecular Dynamic Simulation-Guided Discovery of Potential PAK1 Inhibitors Using Repurposing Approaches.
    Biswal J; Jayaprakash P; Rayala SK; Venkatraman G; Rangaswamy R; Jeyaraman J
    ACS Omega; 2021 Oct; 6(41):26829-26845. PubMed ID: 34693105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WScore: A Flexible and Accurate Treatment of Explicit Water Molecules in Ligand-Receptor Docking.
    Murphy RB; Repasky MP; Greenwood JR; Tubert-Brohman I; Jerome S; Annabhimoju R; Boyles NA; Schmitz CD; Abel R; Farid R; Friesner RA
    J Med Chem; 2016 May; 59(9):4364-84. PubMed ID: 27054459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
    Lather A; Sharma S; Khatkar A
    Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating replacement free energy of binding-site waters in molecular docking.
    Sun H; Zhao L; Peng S; Huang N
    Proteins; 2014 Sep; 82(9):1765-76. PubMed ID: 24549784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modelling approaches predicted 1,2,3-triazolyl ester of ketorolac (15K) to be a novel allosteric modulator of the oncogenic kinase PAK1.
    Shahinozzaman M; Ahmed S; Emran R; Tawata S
    Sci Rep; 2021 Sep; 11(1):17471. PubMed ID: 34471161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
    Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
    Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing limitations with the MM-GB/SA scoring procedure using the WaterMap method and free energy perturbation calculations.
    Guimarães CR; Mathiowetz AM
    J Chem Inf Model; 2010 Apr; 50(4):547-59. PubMed ID: 20235592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
    Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
    J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies.
    Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Phytochemicals Targeting c-Met Kinase Domain using Consensus Docking and Molecular Dynamics Simulation Studies.
    Aliebrahimi S; Montasser Kouhsari S; Ostad SN; Arab SS; Karami L
    Cell Biochem Biophys; 2018 Jun; 76(1-2):135-145. PubMed ID: 28852971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of MDockPP in CAPRI rounds 28-29 and 31-35 including the prediction of water-mediated interactions.
    Xu X; Qiu L; Yan C; Ma Z; Grinter SZ; Zou X
    Proteins; 2017 Mar; 85(3):424-434. PubMed ID: 27802576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the "fingers" domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations.
    Manjula S; Sivanandam M; Kumaradhas P
    J Biomol Struct Dyn; 2019 Jun; 37(9):2440-2456. PubMed ID: 30047829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computational approach to explore and identify potential herbal inhibitors for the p21-activated kinase 1 (PAK1).
    Shahinozzaman M; Ishii T; Ahmed S; Halim MA; Tawata S
    J Biomol Struct Dyn; 2020 Aug; 38(12):3514-3526. PubMed ID: 31448698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational insight into the mechanisms of action and selectivity of Afraxis PAK inhibitors.
    Han D; Wang H; Cui W; Zhang B; Chen BZ
    Future Med Chem; 2020 Mar; 12(5):367-385. PubMed ID: 32064922
    [No Abstract]   [Full Text] [Related]  

  • 19. Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors.
    Tripathi SK; Muttineni R; Singh SK
    J Theor Biol; 2013 Oct; 334():87-100. PubMed ID: 23727278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
    Chaudhari HK; Pahelkar A
    Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.